Latest Earnings Results: Q3 '26
Estimated EPS
$1.20
Reported EPS
$1.23
Surprise
+2.77%
Estimated Rev
$792.39M
Reported Rev
$763.72M
Surprise
-3.62%
• Reported GAAP EPS of $1.23 up 4.24% YoY • Reported revenue of $763.72M down -0.69% YoY • Globus Medical updated full-year 2026 revenue guidance to $3.09B from $3.18B to $3.22B, representing 5.1% growth, and reaffirmed non-GAAP diluted EPS guidance of $4.95 to $5.05.
Bullish Takeaway
Globus Medical reported 24% Enabling Technologies revenue growth and 73% more robot and navigation deployments, eight consecutive quarters of adjusted margin expansion, and a $500M repurchase authorization increase.
Bearish Takeaway
Globus Medical reported Q3 sales decreases, set 2026 revenue guidance below its previous range, and identified competition, surgeon product adoption, and sales-personnel retention as risks.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $1.29 | -- | -- | N/A |
Q3 '26 | $1.20 | $1.23 | 2.77% | BEAT |
Q2 '26 | $1.10 | $1.34 | 21.91% | BEAT |
Q1 '26 | $0.92 | $1.12 | 21.80% | BEAT |
Q4 '25 | $1.13 | $1.28 | 12.89% | BEAT |